# Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease

> **NCT01227681** · PHASE2 · TERMINATED · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 4 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** G-CSF
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01227681
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Difficulty in Recruitment
- **Last updated:** 2016-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227681, "Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01227681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*